BeOne Medicines Ltd.
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Approximate U.S. Employees by Year
Approximate U.S. Employees (Form 10-K Human Capital)
BeOne Medicines Approximate U.S. Employees: 1,900 in FY2025, up 11.8% from a year earlier.
Latest, FY2025
1,900
Period ended Dec 31, 2025
Change on a year earlier
+11.8%
1,700 in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Where the FY2025 figure comes from
“As of February 13, 2026, we had nearly 12,000 full-time employees worldwide, across six continents, with approximately 1,900 employees in the U.S.”
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Item 1 Human Capital Management.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Approximate U.S. Employees (Form 10-K Human Capital) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,900 | +11.8% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 1,700 | +6.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 1,600 | +23.1% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 1,300 | +8.3% | Form 10-K (filed 2023-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 1,200 | – | Form 10-K (filed 2022-02-28) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Approximate U.S. Employees, annual FY2021–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/emp-us-approx
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.